Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.

MLA

Rudrapal, Mithun, and Dipak Chetia. “Endoperoxide Antimalarials: Development, Structural Diversity and Pharmacodynamic Aspects with Reference to 1,2,4-Trioxane-Based Structural Scaffold.” Drug Design, Development and Therapy, vol. 10, Nov. 2016, pp. 3575–90. EBSCOhost, https://doi.org/10.2147/DDDT.S118116.

APA

Rudrapal, M., & Chetia, D. (2016). Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold. Drug Design, Development and Therapy, 10, 3575–3590. https://doi.org/10.2147/DDDT.S118116

Chicago

Rudrapal, Mithun, and Dipak Chetia. 2016. “Endoperoxide Antimalarials: Development, Structural Diversity and Pharmacodynamic Aspects with Reference to 1,2,4-Trioxane-Based Structural Scaffold.” Drug Design, Development and Therapy 10 (November): 3575–90. doi:10.2147/DDDT.S118116.